Aluminum is a neurotoxin and in susceptible species induces a neurofib
rillary pathology characterized by argentophilic masses in neuronal pe
rikarya and in axonal spheroids. These inclusions are known to contain
neurofilament proteins. Using immunocytochemistry and immunoblotting,
we demonstrate that tau is a component of these aluminum-induced neur
ofibrillary tangles (AI-NFTs) in rabbits. Double-label immunocytochemi
stry experiments reveal co-localization of phosphorylated neurofilamen
ts (using SMI31) and tau (using tau-1, tau-5, AT8, and PHF-1) in the p
erikaryal AI-NFTs. Nonphosphorylated tau (detected using tau-1) occupi
es a smaller area of the AI-NFT than the total pool of tau proteins (d
etected using tau-5). The area of fetal tau and non-phosphorylated tau
immunolabeling in the AI-NFT increases as the size of the AI-NFT (i.e
., the proportion of cell area occupied by the AI-NFT) increases. The
proportion of cell area (outside of the AI-NFT) occupied by tau (as in
dicated by tau-5) decreases as the area of tau in the AI-NFT increases
and as the size of the AI-NFT in the cell increases. Immunoblotting e
xperiments demonstrate 1) the specificity of the tau antibody labeling
and verify a lack of cross-reactivity of the tau-5 antibody to neurof
ilament proteins in rabbit tissue; and 2) no alterations in the levels
of tau resulting from aluminum-treatment. These data suggest that as
the size of the AI-NFT in a cell increases there is less tau in the ne
uronal perikarya. Therefore, there may be less tau in the perikarya av
ailable to perform normal functions such as microtubule polymerization
and stabilization. Tau and neurofilament proteins are perturbed in a
number of neurodegenerative disorders such as Alzheimer's disease, dif
fuse Lewy body disease, and Parkinson's disease. Aluminum-induced neur
ofibrillary pathology may provide a model to study perturbations in ta
u and neurofilaments, their phosphorylation and deposition into pathol
ogical inclusions. (C) 1997 Inter Press, Inc.